In vivo CRISPR screen identifies KRAS-induced COX-2 as a driver of immune evasion and immunotherapy resistance in lung cancer https://www.biorxiv.org/content/10.1101/2023.04.13.536740v1?med=mas
In vivo CRISPR screen identifies KRAS-induced COX-2 as a driver of immune evasion and immunotherapy resistance in lung cancer https://www.biorxiv.org/content/10.1101/2023.04.13.536740v1?med=mas